REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/06/2025
Back to search
Official data from USPTO
OPKO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OPKO
ST13
US500000086456085Class
1, 5, 9, 10
Filing
86456085
Registration
5093546
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
12/07/2025
Trademark type
Word
Nice classes
1, 5, 9, 10
Filing date
11/17/2014
Registration date
12/06/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/08/2023
Last transaction
12/07/2025
Responsible office
United States Patent and Trademark Office
Status code
705
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Miami, FL
Examiner
MARESCA,MEREDITH Z
Law office
L90
Holders and representatives
Holders
OPKO Health, Inc.
Representatives
Richard M. LaBarge MARSHALL GERSTEIN & BORUN LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
chemical preparations for scientific purposes; chemical preparationsdiagnostic reagents for scientific or research use
Class 5
diagnostic agentspreparations and substances for medical purposes; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treating diseases and disorders of the parathyroidfor treating secondary hyper-parathyroidism; pharmaceutical preparations for the treatment of vitamin D deficiency ; pharmaceutical preparations for use in renal dialysis and in the treatment of renal diseases and kidney ailments; pharmaceutical preparations in the nature of phosphate binders for use in the treatment of hyperphosphataemial; human growth hormone; medical diagnostic kits comprised of medical diagnostic reagents and assays for testing body fluids
Class 9
computer software for analyzing medical test resultsthe software relating to the scientificpharmaceuticalgeneticmedical and medical diagnostic fields; computer software for operating medical diagnostic apparatusthe software relating to at least one of the scientificpharmaceuticalgeneticmedical and medical diagnostic fields
Class 10
in-vitro diagnostic testing medical instruments for testing blood and other bodily fluids and tissues; medical instruments for use in monitoring the content of bodily fluids; medical apparatus for testing for the presence of particular substances in blood; medical devices for detecting cancer; medical devices for diagnosing vitamin D deficiencies; medical diagnostic apparatus in the nature of a diagnostic card containing medical diagnostic reagents and immunoassays sold together as a kit for at least one of the following: testing body fluidsdiagnosing urological diseasekidney diseasecancervitamin deficiencies
Publications
History of USPTO decisions and trademark events.
41 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/08/2023
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/08/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/08/2023
E815
TEAS SECTION 8 & 15 RECEIVED
12/06/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/06/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
12/06/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/20/2016
PUBO
PUBLISHED FOR OPPOSITION
09/20/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/31/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/18/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/12/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
08/12/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/12/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
08/12/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/12/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/05/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/05/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/29/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/10/2016
GNRT
NON-FINAL ACTION E-MAILED
02/10/2016
CNRT
NON-FINAL ACTION WRITTEN
02/10/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/08/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/08/2016
ALIE
ASSIGNED TO LIE
02/08/2016
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/01/2016
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
12/17/2015
GNSI
INQUIRY TO SUSPENSION E-MAILED
12/17/2015
CNSI
SUSPENSION INQUIRY WRITTEN
12/17/2015
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/17/2015
GNSL
LETTER OF SUSPENSION E-MAILED
06/17/2015
CNSL
SUSPENSION LETTER WRITTEN
06/17/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/16/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/15/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/15/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/17/2014
GNRT
NON-FINAL ACTION E-MAILED
12/17/2014
CNRT
NON-FINAL ACTION WRITTEN
12/17/2014
DOCK
ASSIGNED TO EXAMINER
12/17/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/24/2014
NWAP
NEW APPLICATION ENTERED
11/20/2014
Continuous trademark protection
Get notified about every new filing that threatens OPKO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.